STADA appoints Diana Wiedmann as Chief Culture & People Officer
Diana Wiedmann will become STADA’s Chief Culture & People Officer on 1 January 2027, succeeding Simone Berger in the role.
Diana Wiedmann will become STADA’s Chief Culture & People Officer on 1 January 2027, succeeding Simone Berger in the role.
Lonza has created a Chief Commercial Officer role and appointed Samanta Cimitan, who is set to join the CDMO by early 2027.
Redcare Pharmacy plans a CEO change, with Peter Schmid von Linstow set to succeed Olaf Heinrich in a planned leadership transition.
Sanofi has created a Country President role in Germany. Madeleine Roach will take over the new leadership position from September 2026.
Daiichi Sankyo appoints Markus Kosch to lead its European business from April 2027 and combines Oncology and Specialty in a new structure.
Quanterix has named Jim Gute Chief Commercial Officer, tasking him with leading commercial growth across biomarker testing and diagnostics.
Christoph Straub will step down as BARMER’s board chairman at the end of 2026. Simone Schwering and Uwe Repschläger will follow.
Sandoz has appointed Dr. Simon Goeller as Country President in Germany. He also takes on the CEO role at Hexal.
Medios appoints Katrin Neuffer as Director Investor Relations & Communications. She succeeds Claudia Nickolaus in the capital markets role.
BioNTech has appointed Guido Oelkers to its Management Board. The Sobi CEO is set to succeed Ugur Sahin by February 2027.
Sarepta Therapeutics appoints Michael Severino as CEO. Doug Ingram will retire and support the transition through the end of 2026.
Ying Huang has stepped down as Legend Biotech CEO and board member. Alan Bash will lead the cell therapy company on an interim basis.
Carsten Linnemann is set to take over Germany’s health ministry, while Nina Warken is expected to move to the Chancellery.
Mediengruppe Deutscher Apotheker Verlag is reorganizing its management board in response to changes in its market environment.
Convatec is preparing a CFO change. Fiona Ryder will remain until a successor is appointed, while Tobias Hestler joins the board.
Sanofi will reshape its Executive Committee on September 1, 2026, with changes across R&D, business units, finance and regional roles.
Tarsus Pharmaceuticals says CCO Aziz Mottiwala will depart, with Neera Clase taking over the commercial role on an interim basis.
Christoph Bohlender of MENSCH Kreativagentur joins the COMPRIX advisory board as Dr. Giuseppe Gianni of Brand Health steps down.
Holger Holakovsky has taken over the lead at Boehringer Ingelheim microParts in Dortmund as Simone Schulz moves to a global role.
NOWEDA CEO Dr. Michael Kuck will retire at the end of 2026. Sales board member Udo Harneit is set to take over in January 2027.
Looking for a new partner in pharma and healthcare marketing?
Visit our agency finder